Eosinophil survival

"Eosinophil survival" is **not** the name of a specific molecule, protein, or receptor. Instead, it refers to the biological process governing how long **eosinophils**, which are specialized white blood cells involved in immune responses and inflammation, persist before undergoing programmed cell death (apoptosis). The regulation of their lifespan is critical for both normal immune function and disease states. Key molecular regulators promoting their survival are cytokines such as interleukin‑3 (IL‑3), interleukin‑5 (IL‑5), granulocyte-macrophage colony-stimulating factor (GM-CSF), and chemokines like eotaxins. These factors activate intracellular signaling pathways—most notably the NF-kB/Bcl-xL axis—that inhibit apoptosis within the cell.[1][3][5] Dysregulation leading to prolonged eosinophil survival contributes directly to diseases such as asthma, hypereosinophilic syndromes, certain leukemias/lymphomas with clonal expansion of these cells,[2] and other inflammatory conditions.[4] Several drugs target upstream mediators like IL‑5 or its receptor rather than "eosinophil survival" itself. Because "Eosinophil survival" describes a **cellular process** rather than an individual therapeutic target molecule/receptor/protein/gene/family member, it should not be considered an appropriate canonical entry for structured drug-target databases. The correct approach would be to map queries about "eosinophil survival" toward its key molecular regulators—such as "Interleukin‑5 receptor," "Granulocyte-macrophage colony-stimulating factor receptor," etc.—for which all relevant structured information can be provided. If you need information on one of those specific molecules/receptors regulating this process instead, please specify which one.

Other names

null (no common aliases; this is a biological process, not a molecule or receptor)

Mechanisms of drugs affecting eosinophil survival include: - IL‑5 pathway blockade reduces eosinophil development and promotes apoptosis by inhibiting anti-apoptotic signaling in these cells[1][5].